94236-49-4

Upstream product

• 92762-94-2 β-benzyl-L-aspartic acid amide trifluoroacetate 
• 21947-33-1 4-nitrophenyl (S)-2-((tert-butoxycarbonyl)amino)hexanoate 
• 6404-28-0 Boc-Nle-OH 

Downstream Products

• 121888-37-7 Boc-Asp(OBzl)-Tyr-Nle-Gly-Trp-Nle-gAsp-COCH₂CH₂C₆H₅ 
• 121888-38-8 Boc-Asp-Tyr-Nle-Gly-Trp-Nle-gAsp-COCH₂CH₂C₆H₅ 
• 121888-36-6 Z-Trp-Nle-gAsp(OBzl)-COCH₂CH₂C₆H₅ 
• 121888-35-5 Boc-Nle-gAsp(OBzl)-COCH₂CH₂C₆H₅ 
• 121961-23-7 Boc-Asp-Tyr(SO₃K)-Nle-Gly-Trp-Nle-gAsp-COCH₂CH₂C₆H₅ 

Relevant academic research and scientific papers

Synthesis and biological activity of some partially modified retro-inverso analogues of cholecystokinin

Syntheses of some partially modified retro-inverso analogues of the C-terminal octa- or heptapeptide of cholecystokinin are described. These analogues (in which the C-terminal carboxamide was deleted or not) were obtained by reverting one or several pepti

Structure-activity relationships of C-terminal tri- and tetrapeptide fragments that inhibit gastrin activity

A series of tri- and tetrapeptide derivatives, analogues of the gastrin C-terminal region with no phenylalanine residue, were synthesized. These peptides were tested for their ability to inhibit gastrin-stimulated acid secretion in vivo as well as binding